JP2018505205A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018505205A5 JP2018505205A5 JP2017542401A JP2017542401A JP2018505205A5 JP 2018505205 A5 JP2018505205 A5 JP 2018505205A5 JP 2017542401 A JP2017542401 A JP 2017542401A JP 2017542401 A JP2017542401 A JP 2017542401A JP 2018505205 A5 JP2018505205 A5 JP 2018505205A5
- Authority
- JP
- Japan
- Prior art keywords
- isolating
- pharmaceutically acceptable
- acceptable salt
- disorder
- mixing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WFVZVMGMPBTVBW-VYRBHSGPSA-N CC(C)(C)OC(N(CCC1)[C@@H]1C(c(cc1)c(CCO)cc1F)O)=O Chemical compound CC(C)(C)OC(N(CCC1)[C@@H]1C(c(cc1)c(CCO)cc1F)O)=O WFVZVMGMPBTVBW-VYRBHSGPSA-N 0.000 description 1
- WFVZVMGMPBTVBW-AAFJCEBUSA-N CC(C)(C)OC(N(CCC1)[C@H]1C(c(cc1)c(CCO)cc1F)O)=O Chemical compound CC(C)(C)OC(N(CCC1)[C@H]1C(c(cc1)c(CCO)cc1F)O)=O WFVZVMGMPBTVBW-AAFJCEBUSA-N 0.000 description 1
- MVUVVOWTNVWEFT-PZORYLMUSA-N [O-][NH+](CCC1)[C@H]1C1OCCc2c1ccc(F)c2 Chemical compound [O-][NH+](CCC1)[C@H]1C1OCCc2c1ccc(F)c2 MVUVVOWTNVWEFT-PZORYLMUSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562115064P | 2015-02-11 | 2015-02-11 | |
| US62/115,064 | 2015-02-11 | ||
| PCT/US2016/017539 WO2016130796A1 (en) | 2015-02-11 | 2016-02-11 | 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020018081A Division JP7023994B2 (ja) | 2015-02-11 | 2020-02-05 | Ｃｎｓ疾患を治療するための１－複素環イソクロマニル化合物およびアナログ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018505205A JP2018505205A (ja) | 2018-02-22 |
| JP2018505205A5 true JP2018505205A5 (OSRAM) | 2019-03-22 |
| JP6657241B2 JP6657241B2 (ja) | 2020-03-04 |
Family
ID=55456908
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017542401A Expired - Fee Related JP6657241B2 (ja) | 2015-02-11 | 2016-02-11 | Ｃｎｓ疾患を治療するための１−複素環イソクロマニル化合物およびアナログ |
| JP2020018081A Expired - Fee Related JP7023994B2 (ja) | 2015-02-11 | 2020-02-05 | Ｃｎｓ疾患を治療するための１－複素環イソクロマニル化合物およびアナログ |
| JP2022018580A Pending JP2022065050A (ja) | 2015-02-11 | 2022-02-09 | Ｃｎｓ疾患を治療するための１－複素環イソクロマニル化合物およびアナログ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020018081A Expired - Fee Related JP7023994B2 (ja) | 2015-02-11 | 2020-02-05 | Ｃｎｓ疾患を治療するための１－複素環イソクロマニル化合物およびアナログ |
| JP2022018580A Pending JP2022065050A (ja) | 2015-02-11 | 2022-02-09 | Ｃｎｓ疾患を治療するための１－複素環イソクロマニル化合物およびアナログ |
Country Status (22)
| Country | Link |
|---|---|
| US (4) | US9856238B2 (OSRAM) |
| EP (2) | EP3256466B9 (OSRAM) |
| JP (3) | JP6657241B2 (OSRAM) |
| KR (1) | KR102601972B1 (OSRAM) |
| CN (2) | CN111925360B (OSRAM) |
| AU (1) | AU2016219253C1 (OSRAM) |
| CA (1) | CA2976095C (OSRAM) |
| CY (1) | CY1125198T1 (OSRAM) |
| DK (1) | DK3256466T3 (OSRAM) |
| EA (1) | EA201791804A1 (OSRAM) |
| ES (2) | ES2967643T3 (OSRAM) |
| HU (1) | HUE058698T2 (OSRAM) |
| IL (1) | IL253914B (OSRAM) |
| MX (2) | MX392664B (OSRAM) |
| MY (1) | MY188160A (OSRAM) |
| NZ (1) | NZ735011A (OSRAM) |
| PH (1) | PH12017501422A1 (OSRAM) |
| PL (1) | PL3256466T3 (OSRAM) |
| PT (1) | PT3256466T (OSRAM) |
| SG (2) | SG10201806809QA (OSRAM) |
| UA (1) | UA122222C2 (OSRAM) |
| WO (1) | WO2016130796A1 (OSRAM) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3256466B9 (en) * | 2015-02-11 | 2022-07-27 | Sunovion Pharmaceuticals Inc. | 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders |
| MX371197B (es) * | 2015-02-11 | 2020-01-22 | Sunovion Pharmaceuticals Inc | Compuestos de dihidro-4h-pirazolo [5,1-c] [1,4] oxazinilo y análogos para el tratamiento de trastornos del sistema nervioso central (snc). |
| WO2018023070A1 (en) | 2016-07-29 | 2018-02-01 | Sunovion Pharmaceuticals, Inc. | Compounds and compositions and uses thereof |
| MY199446A (en) | 2016-07-29 | 2023-10-28 | Sunovion Pharmaceuticals Inc | Compounds and compositions and uses thereof |
| KR20250069704A (ko) | 2017-06-30 | 2025-05-19 | 체이스 테라퓨틱스 코포레이션 | 우울증을 치료하기 위한 nk-1 길항제 조성물 및 우울증 치료에 사용하는 방법 |
| KR20200036008A (ko) | 2017-08-02 | 2020-04-06 | 선오비온 파마슈티컬스 인코포레이티드 | 이소크로만 화합물 및 이의 용도 |
| EP3870292A4 (en) | 2018-10-26 | 2022-11-09 | The Research Foundation for The State University of New York | COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA |
| CN113784755B (zh) | 2019-03-14 | 2024-05-10 | 赛诺维信制药公司 | 异色满基化合物的盐及其结晶形式、制备方法、治疗用途和药物组合物 |
| US12077546B2 (en) | 2021-04-10 | 2024-09-03 | Sumitomo Pharma Co., Ltd. | Bicyclic pyridine derivative |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3438995A (en) | 1968-01-08 | 1969-04-15 | Melville Sahyun | Diazaheterocyclic substituted benz-oxaheterocyclic compounds |
| US4963568A (en) | 1989-05-31 | 1990-10-16 | Abbott Laboratories | Dopamine agonists |
| US5621133A (en) | 1989-05-31 | 1997-04-15 | Deninno; Michael P. | Dopamine agonists |
| IE73232B1 (en) * | 1990-05-25 | 1997-05-21 | Akzo Nv | Isochromane derivatives |
| US5238939A (en) * | 1990-05-25 | 1993-08-24 | Akzo N.V. | Isochromane derivatives |
| JP2002519348A (ja) | 1998-06-30 | 2002-07-02 | イーライ・リリー・アンド・カンパニー | ５−ｈｔ１ｆアゴニスト |
| SE9902267D0 (sv) * | 1999-06-16 | 1999-06-16 | Astra Ab | New compounds |
| JP2005510518A (ja) * | 2001-11-08 | 2005-04-21 | セプラコール， インク． | シタロプラムのデスメチル代謝産物及びジデスメチル代謝産物の濃縮された鏡像異性体を用いてうつ病及び他のｃｎｓ障害を治療する方法 |
| BRPI0515830A (pt) * | 2004-12-21 | 2008-08-05 | F Hoffmann La Roche | derivados de cromano e usos dos mesmos no tratamento de distúrbios do sistema nervoso central |
| GT200600166A (es) | 2005-04-22 | 2007-03-14 | Derivados de cromano y cromeno y usos de los mismos | |
| AU2007209382A1 (en) * | 2006-01-27 | 2007-08-02 | F. Hoffmann-La Roche Ag | Use of 2-imidazoles for the treatment of CNS disorders |
| KR101103118B1 (ko) | 2007-11-02 | 2012-01-04 | 동아제약주식회사 | 신규한 1,3-디히드로-5-이소벤조퓨란카르보니트릴 유도체 화합물 및 이를 함유하는 조루증 치료용 약학조성물 |
| MX388468B (es) * | 2009-12-04 | 2025-03-20 | Sunovion Pharmaceuticals Inc | Compuestos multicíclicos y métodos de uso de los mismos. |
| EP2683710B1 (en) | 2011-03-10 | 2017-07-19 | Boehringer Ingelheim International GmbH | Soluble guanylate cyclase activators |
| AR090557A1 (es) * | 2012-04-02 | 2014-11-19 | Orion Corp | DERIVADOS IMIDAZOLICOS AGONISTAS ADRENERGICOS a2 |
| JP6359560B2 (ja) * | 2012-12-31 | 2018-07-18 | サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． | 複素環式化合物及びその使用方法 |
| EP3256466B9 (en) * | 2015-02-11 | 2022-07-27 | Sunovion Pharmaceuticals Inc. | 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders |
-
2016
- 2016-02-11 EP EP16708262.7A patent/EP3256466B9/en active Active
- 2016-02-11 CN CN202010607608.6A patent/CN111925360B/zh active Active
- 2016-02-11 CN CN201680018639.XA patent/CN107531674B/zh active Active
- 2016-02-11 MY MYPI2017702923A patent/MY188160A/en unknown
- 2016-02-11 UA UAA201708945A patent/UA122222C2/uk unknown
- 2016-02-11 CA CA2976095A patent/CA2976095C/en active Active
- 2016-02-11 WO PCT/US2016/017539 patent/WO2016130796A1/en not_active Ceased
- 2016-02-11 HU HUE16708262A patent/HUE058698T2/hu unknown
- 2016-02-11 NZ NZ735011A patent/NZ735011A/en not_active IP Right Cessation
- 2016-02-11 PT PT167082627T patent/PT3256466T/pt unknown
- 2016-02-11 AU AU2016219253A patent/AU2016219253C1/en not_active Ceased
- 2016-02-11 KR KR1020177025290A patent/KR102601972B1/ko active Active
- 2016-02-11 EP EP22166538.3A patent/EP4046995B1/en active Active
- 2016-02-11 DK DK16708262.7T patent/DK3256466T3/da active
- 2016-02-11 ES ES22166538T patent/ES2967643T3/es active Active
- 2016-02-11 EA EA201791804A patent/EA201791804A1/ru unknown
- 2016-02-11 SG SG10201806809QA patent/SG10201806809QA/en unknown
- 2016-02-11 JP JP2017542401A patent/JP6657241B2/ja not_active Expired - Fee Related
- 2016-02-11 ES ES16708262T patent/ES2911910T3/es active Active
- 2016-02-11 SG SG11201706515QA patent/SG11201706515QA/en unknown
- 2016-02-11 MX MX2020001157A patent/MX392664B/es unknown
- 2016-02-11 MX MX2017010363A patent/MX371404B/es active IP Right Grant
- 2016-02-11 US US15/041,852 patent/US9856238B2/en active Active
- 2016-02-11 PL PL16708262T patent/PL3256466T3/pl unknown
-
2017
- 2017-08-08 IL IL253914A patent/IL253914B/en unknown
- 2017-08-09 PH PH12017501422A patent/PH12017501422A1/en unknown
- 2017-11-21 US US15/819,372 patent/US10336732B2/en active Active
-
2019
- 2019-05-06 US US16/403,698 patent/US11192885B2/en active Active
-
2020
- 2020-02-05 JP JP2020018081A patent/JP7023994B2/ja not_active Expired - Fee Related
-
2021
- 2021-10-29 US US17/452,786 patent/US20220185799A1/en not_active Abandoned
-
2022
- 2022-02-09 JP JP2022018580A patent/JP2022065050A/ja active Pending
- 2022-05-20 CY CY20221100352T patent/CY1125198T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018505205A5 (OSRAM) | ||
| AU2022200946B2 (en) | Modulators of the integrated stress pathway | |
| CN103534258B (zh) | 酪氨酸激酶抑制剂 | |
| JP2015508092A5 (OSRAM) | ||
| ES2878030T3 (es) | Inhibidores de tirosina cinasa | |
| JP2018193405A5 (OSRAM) | ||
| JP2018505204A5 (OSRAM) | ||
| CN104487441B (zh) | 有用于治疗癌症和自身免疫性疾病的可逆的共价吡咯并嘧啶或吡唑并嘧啶 | |
| JP2022043078A5 (OSRAM) | ||
| JP7541594B2 (ja) | ＰＩ３Ｋ－γ阻害剤としての三級ヒドロキシ基で置換された縮合イミダゾール誘導体 | |
| CN102985418B (zh) | 凋亡信号调节激酶抑制剂 | |
| JP2020511461A5 (OSRAM) | ||
| JP2013032389A5 (OSRAM) | ||
| JP2016512563A5 (OSRAM) | ||
| JP2019525939A5 (OSRAM) | ||
| CN106456652A (zh) | Btk抑制剂的盐和固体形式 | |
| JP2010520264A5 (OSRAM) | ||
| JP2004527467A5 (OSRAM) | ||
| JP2014528485A5 (OSRAM) | ||
| PE20170004A1 (es) | Inhibidores de biaril cinasa | |
| JP2013542261A5 (OSRAM) | ||
| JP2014512451A5 (OSRAM) | ||
| JP2017514910A5 (OSRAM) | ||
| CN103502249A (zh) | 作为酪氨酸激酶抑制剂的氮杂吲哚衍生物 | |
| JP2015536307A5 (OSRAM) |